Table 2.3.
Parameter | Score |
---|---|
Family history First degree relative with premature vascular/coronary disease (men < 55 years, women < 60 years) OR First or second degree relative with TC > 290 mg/dL* First degree relative with tendon xanthoma and/or corneal arcus OR First degree relative < 16 years with TC > 260 mg/dL* |
1 2 |
Clinical history Patient with premature CAD (men < 55 years, women < 60 years) Patient with premature cerebral or peripheral arterial disease (men < 55 years, women < 60 years) |
2 1 |
Physical examination Tendon xanthoma Corneal arcus < 45 years |
6 4 |
LDL-c Levels (mg/dL) ≥ 330 mg/dL 250 - 329 mg/dL 190 - 249 mg/dL 155 - 189 mg/dL |
8 5 3 1 |
DNA analysis Functional mutation in the LDL receptor, the ApoB100, or the PCSK9* gene |
8 |
FH diagnosis Confirmed if Potential if Possible if Not FH |
> 8 points 6 - 8 points 3 - 5 points < 3 points |
CAD: coronary artery disease; DNA: deoxyribonucleic acid; FH: familial hypercholesterolemia; LDL-c: low-density lipoprotein-cholesterol; TC: total cholesterol.
Modified from the Dutch MEDPED, adopting a criterion from the Simon Broome Register Group proposal. Adapted from the Updated Guideline for Dyslipidemia and Atherosclerosis Prevention (5) and the I Brazilian Guidelines for Familial Hypercholesterolemia.19